Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy 2.4 mg is the standard maintenance dose of semaglutide for weight management in the UK, available only on a private prescription following clinical assessment. Private monthly costs typically run from around £149 to £375 depending on dose and provider, figures that have shifted since Eli Lilly's competitors adjusted supply in 2025. Wegovy is a prescription-only medicine; a prescriber decides whether it is clinically appropriate for you, and no legitimate UK pharmacy can supply it without that step. What reviews often skip over is exactly how those headline prices are built, and what they quietly leave out.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most Wegovy price reviews lead with a single figure. That figure is almost always just the pen. What it rarely includes is the consultation, the prescription, the delivery charge, or access to a prescriber if something changes on your next dose. By the time you add those pieces, the total can look quite different from what the headline promised.
Private weight-loss treatment in the UK is priced per pen or per four-week supply, and it varies between providers, by dose, and by what is bundled in. According to NHS guidance on semaglutide, Wegovy is a prescription-only medicine, which means a prescriber must assess you before it can be dispensed. That assessment has a cost. Some providers absorb it; many do not. The reviews that compare two headline prices without noting whether a consultation fee applies are, frankly, comparing different things.
There is also the question of aftercare. If you have a question about nausea at week three, or you want to discuss a dose review, some services charge separately for that contact. Others include it. The price on the listing will not tell you which you are buying into.
Wegovy treatment begins at 0.25 mg and is titrated upward by a prescriber, typically over several months, through 0.5 mg, 1.0 mg, and 1.7 mg before reaching 2.4 mg maintenance. That matters for cost because you are not paying the 2.4 mg price from day one. Early pens cost less; the maintenance price comes later. If you want to understand what the Wegovy 2.4 mg dose costs once you reach maintenance, it is worth knowing that a review quoting only that figure without mentioning the titration journey can give the impression that treatment is more expensive upfront than it is, or more uniform than it is.
If you want a sense of how costs shift across the dose ladder, the 1 mg pen pricing page gives a useful comparison point mid-titration, and the full Wegovy pricing overview sets out the broader picture across all doses.
NICE recommends semaglutide for weight management under specific conditions, including use within specialist weight management services for a maximum of two years. The NICE technology appraisal TA875 sets out those criteria in full. Private treatment operates outside that pathway, which is why costs fall to the patient rather than the NHS.
At nume, a single transparent price covers the consultation, the prescription, the treatment itself, and free next-working-day delivery. Our prescribers review every order personally before anything is dispatched, and every repeat is clinically reassessed rather than auto-renewed. If you order before 12pm on a working day and your case is approved, DPD collects the same afternoon.
We are not the cheapest option in the market. That is deliberate. Cheapest is not a race worth entering when the product is a prescription medicine that requires a clinical decision to supply safely. A price that seems unusually low is worth scrutinising, legitimate supply through the licensed UK supply chain has a floor, and prices far below the market range are a signal worth taking seriously.
You can verify any online pharmacy on the GPhC register at pharmacyregulation.org. nume's registration number is 9012878. The MHRA has publicly warned about fake weight-loss pens sold online, including counterfeit semaglutide products; if you see Wegovy offered without a clinical assessment or at prices well outside the typical range, that is a red flag worth reporting to the MHRA's Yellow Card scheme.
The right question is not which listing is cheapest. It is which service gives you a genuine clinical assessment, a real prescription from a registered prescriber, genuine product through an authorised supply chain, and support if something goes wrong. Those things have a cost, and that cost is part of what keeps you safe.
Reviews that rank providers purely by headline price tend to filter out the services that include the most. If a provider charges separately for the consultation, the prescription, the delivery, and any follow-up calls, the total may well exceed a service that bundles everything. The cheapest Wegovy 2.4 mg guide unpacks this further for readers who want to compare properly.
For a fuller look at how the overall cost of semaglutide treatment stacks up, readers often find it helpful to check how the Wegovy 2.4 mg pen is priced alongside the Wegovy 2.4 mg cost page, which covers what goes into private treatment pricing and how to read a quote. Our clinical team reviews every consultation individually, the same day you submit it, not at some point in the coming days. When you are ready to find out whether Wegovy is clinically appropriate for you, the place to start is a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.